Terms: = Lung cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
98 results:
1. The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses.
Ogunjinmi OD; Abdullahi T; Somji RA; Bevan CL; Barclay WS; Temperton N; Brooke GN; Giotis ES
J Med Virol; 2024 Mar; 96(3):e29540. PubMed ID: 38529542
[TBL] [Abstract] [Full Text] [Related]
2. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
3. Single-Cell Transcriptomics Reveals Pre-existing COVID-19 Vulnerability Factors in lung cancer Patients.
Liu W; Li W; Zhao Z
Mol Cancer Res; 2024 Mar; 22(3):240-253. PubMed ID: 38063850
[TBL] [Abstract] [Full Text] [Related]
4. The Value of Combined Detection of Serum PSA, MALAT1 and tmprss2-ETV1 in Evaluating the Progress and Prognosis of Prostate cancer.
Zhao G; Pan Z; Wang P
Arch Esp Urol; 2023 Oct; 76(8):555-562. PubMed ID: 37960954
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry.
Liu Y; Chen D; Wang Y; Li X; Qiu Y; Zheng M; Song Y; Li G; Song C; Liu T; Zhang Y; Guo JT; Lin H; Zhao X
J Virol; 2023 Sep; 97(9):e0060123. PubMed ID: 37676001
[TBL] [Abstract] [Full Text] [Related]
6. Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.
Das A; Meng W; Liu Z; Hasib MM; Galloway H; Ramos da Silva S; Chen L; Sica GL; Paniz-Mondolfi A; Bryce C; Grimes Z; Sordillo EM; Cordon-Cardo C; Rivera KP; Flores M; Chiu YC; Huang Y; Gao SJ
J Med Virol; 2023 Aug; 95(8):e29009. PubMed ID: 37563850
[TBL] [Abstract] [Full Text] [Related]
7. Club-like cells in proliferative inflammatory atrophy of the prostate.
Huang FW; Song H; Weinstein HN; Xie J; Cooperberg MR; Hicks J; Mummert L; De Marzo AM; Sfanos KS
J Pathol; 2023 Sep; 261(1):85-95. PubMed ID: 37550827
[TBL] [Abstract] [Full Text] [Related]
8. Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
Qiao Y; Wotring JW; Zheng Y; Zhang CJ; Zhang Y; Jiang X; Pretto CD; Eyunni S; Parolia A; He T; Cheng C; Cao X; Wang R; Su F; Ellison SJ; Wang Y; Qin J; Yan H; Zhou Q; Ma L; Sexton JZ; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2221809120. PubMed ID: 37459541
[TBL] [Abstract] [Full Text] [Related]
9. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E; Rawlik K; Bretherick AD; Qi T; Wu Y; Nassiri I; McConkey GA; Zechner M; Klaric L; Griffiths F; Oosthuyzen W; Kousathanas A; Richmond A; Millar J; Russell CD; Malinauskas T; Thwaites R; Morrice K; Keating S; Maslove D; Nichol A; Semple MG; Knight J; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Begg C; Walsh T; Tenesa A; Flores C; Riancho JA; Rojas-Martinez A; Lapunzina P; ; ; ; ; Yang J; Ponting CP; Wilson JF; Vitart V; Abedalthagafi M; Luchessi AD; Parra EJ; Cruz R; Carracedo A; Fawkes A; Murphy L; Rowan K; Pereira AC; Law A; Fairfax B; Hendry SC; Baillie JK
Nature; 2023 May; 617(7962):764-768. PubMed ID: 37198478
[TBL] [Abstract] [Full Text] [Related]
10. PM2.5 promotes lung cancer progression through activation of the AhR-tmprss2-IL18 pathway.
Wang TH; Huang KY; Chen CC; Chang YH; Chen HY; Hsueh C; Liu YT; Yang SC; Yang PC; Chen CY
EMBO Mol Med; 2023 Jun; 15(6):e17014. PubMed ID: 36975376
[TBL] [Abstract] [Full Text] [Related]
11. Apalutamide Prevents SARS-CoV-2 Infection in lung Epithelial Cells and in Human Nasal Epithelial Cells.
Majidipur A; Morin-Dewaele M; Gaspar Lopes J; Berry F; Fouchet J; Bartier S; Dufros Duval A; Soyeux P; Huet E; Louis B; Coste A; Béquignon É; Saldana C; Le Corvoisier P; Destouches D; Pawlotsky JM; de la Taille A; Vacherot F; Bruscella P; Firlej V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834705
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis of SARS-CoV-2 receptor proteins in human respiratory tissues identifies alveolar macrophages as potential virus entry site.
Bräutigam K; Reinhard S; Wartenberg M; Forster S; Greif K; Granai M; Bösmüller H; Klingel K; Schürch CM
Histopathology; 2023 May; 82(6):846-859. PubMed ID: 36700825
[TBL] [Abstract] [Full Text] [Related]
13. Impact of
Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
[TBL] [Abstract] [Full Text] [Related]
14. Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Higashi-Kuwata N; Yabe SG; Fukuda S; Nishida J; Tamura-Nakano M; Hattori SI; Okochi H; Mitsuya H
Microbiol Spectr; 2022 Dec; 10(6):e0349022. PubMed ID: 36314907
[TBL] [Abstract] [Full Text] [Related]
15. Smoking modulates different secretory subpopulations expressing SARS-CoV-2 entry genes in the nasal and bronchial airways.
Xu K; Shi X; Husted C; Hong R; Wang Y; Ning B; Sullivan TB; Rieger-Christ KM; Duan F; Marques H; Gower AC; Xiao X; Liu H; Liu G; Duclos G; Platt M; Spira AE; Mazzilli SA; Billatos E; Lenburg ME; Campbell JD; Beane JE
Sci Rep; 2022 Oct; 12(1):18168. PubMed ID: 36307504
[TBL] [Abstract] [Full Text] [Related]
16. Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.
Wagoner J; Herring S; Hsiang TY; Ianevski A; Biering SB; Xu S; Hoffmann M; Pöhlmann S; Gale M; Aittokallio T; Schiffer JT; White JM; Polyak SJ
Microbiol Spectr; 2022 Oct; 10(5):e0333122. PubMed ID: 36190406
[TBL] [Abstract] [Full Text] [Related]
17. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19.
Pietzner M; Chua RL; Wheeler E; Jechow K; Willett JDS; Radbruch H; Trump S; Heidecker B; Zeberg H; Heppner FL; Eils R; Mall MA; Richards JB; Sander LE; Lehmann I; Lukassen S; Wareham NJ; Conrad C; Langenberg C
Nat Commun; 2022 Aug; 13(1):4484. PubMed ID: 35970849
[TBL] [Abstract] [Full Text] [Related]
18. Heterogeneous expression of ACE2, tmprss2, and FURIN at single-cell resolution in advanced non-small cell lung cancer.
Liu Z; Gu X; Li Z; Shan S; Wu F; Ren T
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3563-3573. PubMed ID: 35960376
[TBL] [Abstract] [Full Text] [Related]
19. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.
Biering SB; Sarnik SA; Wang E; Zengel JR; Leist SR; Schäfer A; Sathyan V; Hawkins P; Okuda K; Tau C; Jangid AR; Duffy CV; Wei J; Gilmore RC; Alfajaro MM; Strine MS; Nguyenla X; Van Dis E; Catamura C; Yamashiro LH; Belk JA; Begeman A; Stark JC; Shon DJ; Fox DM; Ezzatpour S; Huang E; Olegario N; Rustagi A; Volmer AS; Livraghi-Butrico A; Wehri E; Behringer RR; Cheon DJ; Schaletzky J; Aguilar HC; Puschnik AS; Button B; Pinsky BA; Blish CA; Baric RS; O'Neal WK; Bertozzi CR; Wilen CB; Boucher RC; Carette JE; Stanley SA; Harris E; Konermann S; Hsu PD
Nat Genet; 2022 Aug; 54(8):1078-1089. PubMed ID: 35879412
[TBL] [Abstract] [Full Text] [Related]
20. Exercise-induced myokines downregulates the ACE2 level in bronchial epithelial cells: Implications for SARS-CoV-2 prevention.
Bhardwaj V; Dela Cruz M; Subramanyam D; Kumar R; Markan S; Parker B; Roy HK
PLoS One; 2022; 17(7):e0271303. PubMed ID: 35857747
[TBL] [Abstract] [Full Text] [Related]
[Next]
